AMENDMENT NO. 1 TO
SELLING AGREEMENT
THIS AMENDMENT NO. 1 TO SELLING AGREEMENT (this
“ Amendment ”) is dated as of July 11,
2008, by and among Dr. Tattoff, Inc. (formerly Lifesciences
Opportunities Incorporated), a Florida corporation located at 8500
Wilshire Boulevard, Suite 105, Beverly Hills, CA 90211 (the “
Seller ”), and Dawson James Securities,
Inc., a Florida corporation located at 925 S. Federal Highway, 6th
Floor, Boca Raton, FL 33432 (the “ Selling
Agent ”).
WHEREAS, the parties entered into that certain
Amended and Restated Selling Agreement, dated March 31, 2008, by
and among the Seller and Selling Agent, a copy of which is attached
hereto as Exhibit A (the “ Agreement
”).
WHEREAS, the Seller and the Selling Agent wish
to amend certain provisions of the Agreement as set forth
herein;
NOW, THEREFORE, for and in consideration of the
mutual promises and covenants other agreements contained in this
Amendment, the Seller and the Selling Agent hereby agree to amend
the Agreement as follows:
1. Defined Terms; Conflicting
Documents . All capitalized terms used but not defined
herein shall have the meaning set forth in the Agreement. In the
event of any conflict between the Agreement and this Amendment,
this Amendment shall prevail and govern.
2.
Amendment to Certain
References . As
a result of the Seller’s recent change in legal corporate
name, all references to “Lifesciences Opportunities
Incorporated” throughout the Agreement shall be deleted in
their entirety and replaced with “Dr. Tattoff,
Inc.”
3.
Amendment to the
Introductory Paragraphs . The second paragraph of the Introductory
Paragraphs of the Agreement is hereby deleted in its entirety and
replaced with the following paragraph:
The Seller proposes to offer and sell (the
“Offering”), to selected investors, upon the terms set
forth herein and in the Subscription Package dated July 9, 2008
(which collectively, together with the attachments and exhibits
thereto, is referred to as the “
